Clinical Efficacy
In male and female patients, the incidence of appropriate shocks was
comparable, but with a higher tendency in females. In 1998, Auricchio et
al. presented successfully arrhythmia detection and defibrillation in 9
patients out of 10[22]. Other randomized trials showed the safety
and efficacy of WCD in the termination of VT/VF. In this regard, first
shock success was in 79 of 80 (99%) among all patients from whom were
74% male participants, respectively [23].